Correlation of the interleukin-5 level in sputum and serum in asthma patients with the different polymorphism by C703-T (IL-5 gene) Source: Eur Respir J 2001; 18: Suppl. 33, 371s Year: 2001
Th1/Th2 cytokine gene polymorphisms in patients with idiopathic pulmonary fibrosis Source: Annual Congress 2005 - Progresses in lung fibrosis Year: 2005
Inflammatory and regulatory cytokine IL-6 in plasma and BAL fluid of patients with pulmonary sarcoidosis Source: Annual Congress 2009 - Bronchoalveolar lavage and phenotyping in diffuse parenchymal lung disease Year: 2009
TNF-alpha and TNF-beta gene polymorphism in pulmonary sarcoidosis patients Source: Eur Respir J 2006; 28: Suppl. 50, 520s Year: 2006
Correlation of eotaxin-3 gene expression and other IL-13-induced genes in patients with asthma Source: Virtual Congress 2021 – New insight into the immunology of allergies, asthma and COPD: from mouse to man Year: 2021
Relationship between IL-8, IL-10, MMP-9 and morphological findings in BAL fluid of patients with interstitial lung diseases Source: Eur Respir J 2003; 22: Suppl. 45, 225s Year: 2003
Cytokine and protein profile in BAL from patients with sarcoidosis and IPF Source: Eur Respir J 2001; 18: Suppl. 33, 195s Year: 2001
The relationship of IL-4 cytokine gene polymorphisms, HRCT and histopathological score in patients with idiopathic pulmonary fibrosis Source: Annual Congress 2011 - Genetic and molecular background in pulmonary fibrosis Year: 2011
Relationship between levels of IL-6 in the lungs in patients with idiopathic interstitial pneumonia and polymorphism -174 G / C promoter of the IL6 gene Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in non-neoplastic and neoplastic lung diseases Year: 2010
Pro- and anti-inflammatory cytokines TNF-alpha, IFN-gamma, IL-10 and TGF-beta1 levels in blood serum as markers of plasmaferesis success and inflammation activity in lung sarcoidosis (LS) Source: Eur Respir J 2006; 28: Suppl. 50, 676s Year: 2006
TNF-a and IL-10 control macrophage expression of CXCL13, a prognostic biomarker of idiopathic pulmonary fibrosis Source: International Congress 2018 – Back to basics and translational research in idiopathic interstitial pneumonias Year: 2018
Pro-inflammatory cytokine changes in patients with cancer after BAL Source: Eur Respir J 2004; 24: Suppl. 48, 82s Year: 2004
Expression of mRNA encoding IL-8 and CXCR‘s in blood and lavage of COPD patients Source: Eur Respir J 2007; 30: Suppl. 51, 584s Year: 2007
BALF cells expression phenotypes and cytokine levels in BALF supernatant in fibrosing interstitial lung diseases Source: Annual Congress 2012 - Diffuse parenchymal lung disease II Year: 2012
Determination of IL-8 concentration and the activity of β-glucuronidase in BAL samples in children with inflammatory lung disease Source: Annual Congress 2010 - From viral bronchiolitis to recurrent pneumonia in childhood: diagnosis, treatment and underlying factors Year: 2010
Correlation of IL-1 alpha and IL-4 promotor region gene polymorphisms and clinical parameters in idiopathic pulmonary fibrosis Source: Annual Congress 2006 - Systemic diseases, environmental and genetic factors in interstitial lung disease Year: 2006
Decreased levels of CXC angiogenic chemokines (IL-8, ENA-78 and GRO-α) in BALF after interferon gamma-1b treatment in IPF patients Source: Eur Respir J 2005; 26: Suppl. 49, 267s Year: 2005
Serum levels of IL-10 and IL-12 i patients with pulmonary sarcoidosis Source: Annual Congress 2009 - Inflammation and airways Year: 2009
Different concentrations of CCL18 in serum and BALF of ILDs: A marker of pulmonary inflammation? Source: Annual Congress 2010 - Usefulness of bronchoalveolar lavage in diffuse parenchymal lung disease Year: 2010